AGT and cholangiocarcinoma: Angiotensin-converting enzyme (ACE) promotes the conversion to the active ligand, angiotensin II (Ang II), from angiotensin I [66], and Ang II and its receptor AT1R as a GPCR contribute to the pathogenesis of CC.